Matches in SemOpenAlex for { <https://semopenalex.org/work/W72889621> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W72889621 endingPage "36" @default.
- W72889621 startingPage "619" @default.
- W72889621 abstract "Until such time as results of more rigorous studies are available, the morbidity rates for thyroid dysfunction cited here must suffice. The 1955 to 1956 outpatient incidence for England and Wales was 1.1 per 1,000 for thyrotoxicosis and 1.7 per 1,000 for myxedema (18). United States in-patient incidence for 1971 was 0.16 per 1,000 for thyrotoxicosis and 0.13 per 1,000 for myxedema (25). The 1935 to 1967 average annual incidence of Graves' disease for females in Olmsted County, Minnesota, was 30.5 per 100,000 (10). Well over 50% of hyperthyroid patients have clinical evidence of mild or moderate muscle weakness. Usually this weakness is proximal, and electro-myography and muscle biopsy confirm the existence of myopathic process (Table 11). Severe muscular weakness of acute onset is relatively rare and is encountered in approximately 1% of hyperthyroid patients (11,17,40). Ophthalmoplegia and psychosis are reported 4% and 2% of patients, respectively (17). Myasthenia gravis, although well publicized, is estimated to occur in less than 1% of patients (3,30). TPP is virtually nonexistent in the West; in the Orient it is reported in 2 to 8% of hyperthyroid patients and is 20 to 60 times more frequent in the hyperthyroid male than in the hyperthyroid female (Table 12). The neurologic symptomatology of myxedema is more extensive, and agreement among the various series is poor. The only unselected series addressing itself to neuromuscular manifestations of myxedema that is suitable for citation is that of Scarpalezos et al. (36). This comprehensive study was done without apparent patient selection, and it reported 2% of patients with definite carpal tunnel syndrome, 6% with myopathy, and 18% with polyneuropathy (Table 13). Reported percentages of hypothyroid patients found to have neurologic manifestations of cerebellar dysfunction are extremely diverse: ataxic gait was reported in 5 to 32% (6,7,12,27) of patients and dysdiadochokinesia in 6 to 52% (7,12,27). Psychosis is encountered in 2 to 5% (6,14,17,27,39) of myxedematous patients, memory loss in 23 to 55% (6,14,27), and coma in less than 1% (27)." @default.
- W72889621 created "2016-06-24" @default.
- W72889621 creator A5048992992 @default.
- W72889621 date "1978-01-01" @default.
- W72889621 modified "2023-09-23" @default.
- W72889621 title "Neurologic complications of thyroid dysfunction." @default.
- W72889621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/742545" @default.
- W72889621 hasPublicationYear "1978" @default.
- W72889621 type Work @default.
- W72889621 sameAs 72889621 @default.
- W72889621 citedByCount "15" @default.
- W72889621 countsByYear W728896212012 @default.
- W72889621 countsByYear W728896212014 @default.
- W72889621 countsByYear W728896212015 @default.
- W72889621 countsByYear W728896212016 @default.
- W72889621 countsByYear W728896212018 @default.
- W72889621 countsByYear W728896212021 @default.
- W72889621 crossrefType "journal-article" @default.
- W72889621 hasAuthorship W72889621A5048992992 @default.
- W72889621 hasConcept C120665830 @default.
- W72889621 hasConcept C121332964 @default.
- W72889621 hasConcept C126322002 @default.
- W72889621 hasConcept C141071460 @default.
- W72889621 hasConcept C187212893 @default.
- W72889621 hasConcept C2775934546 @default.
- W72889621 hasConcept C2776418732 @default.
- W72889621 hasConcept C2778105408 @default.
- W72889621 hasConcept C2779999465 @default.
- W72889621 hasConcept C2780101021 @default.
- W72889621 hasConcept C2780176905 @default.
- W72889621 hasConcept C2780247198 @default.
- W72889621 hasConcept C2781194658 @default.
- W72889621 hasConcept C526584372 @default.
- W72889621 hasConcept C61511704 @default.
- W72889621 hasConcept C71924100 @default.
- W72889621 hasConceptScore W72889621C120665830 @default.
- W72889621 hasConceptScore W72889621C121332964 @default.
- W72889621 hasConceptScore W72889621C126322002 @default.
- W72889621 hasConceptScore W72889621C141071460 @default.
- W72889621 hasConceptScore W72889621C187212893 @default.
- W72889621 hasConceptScore W72889621C2775934546 @default.
- W72889621 hasConceptScore W72889621C2776418732 @default.
- W72889621 hasConceptScore W72889621C2778105408 @default.
- W72889621 hasConceptScore W72889621C2779999465 @default.
- W72889621 hasConceptScore W72889621C2780101021 @default.
- W72889621 hasConceptScore W72889621C2780176905 @default.
- W72889621 hasConceptScore W72889621C2780247198 @default.
- W72889621 hasConceptScore W72889621C2781194658 @default.
- W72889621 hasConceptScore W72889621C526584372 @default.
- W72889621 hasConceptScore W72889621C61511704 @default.
- W72889621 hasConceptScore W72889621C71924100 @default.
- W72889621 hasLocation W728896211 @default.
- W72889621 hasOpenAccess W72889621 @default.
- W72889621 hasPrimaryLocation W728896211 @default.
- W72889621 hasRelatedWork W1976872060 @default.
- W72889621 hasRelatedWork W1990022210 @default.
- W72889621 hasRelatedWork W2159678838 @default.
- W72889621 hasRelatedWork W2408332588 @default.
- W72889621 hasRelatedWork W2497134504 @default.
- W72889621 hasRelatedWork W2605607543 @default.
- W72889621 hasRelatedWork W2751391056 @default.
- W72889621 hasRelatedWork W2766563898 @default.
- W72889621 hasRelatedWork W3202048764 @default.
- W72889621 hasRelatedWork W72889621 @default.
- W72889621 hasVolume "19" @default.
- W72889621 isParatext "false" @default.
- W72889621 isRetracted "false" @default.
- W72889621 magId "72889621" @default.
- W72889621 workType "article" @default.